logo
15:56 Dec 12

Nectar Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
21.04
+0.10 (+0.48%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Nectar Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
21.04
+0.10 (+0.48%)
15:56 Dec 12
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

5

Weakness

8

Opportunity

0

Threats

0

-11.88 %

ROE %

-5.55 %

ROA %

-16.12

EPS

42.63

BVPS

-6.80 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1668.83 1523.67 1684.09 1669.97 1171.34
Operating Expenses +
1510.29 1470.66 1532.53 1699.53 1343.86
Raw Material
1207.32 1200.84 1242.45 1250.72 939.33
Increase Decrease in Cost
15.81 -41.55 -40.21 117.29 162.18
Other Manufacturing Expense
146.37 172.14 184.64 163.22 0
Employee Cost
74.55 77.78 84.67 96.48 73.32
Miscellaneous Expenses
67.12 61.45 60.98 71.82 169.03
Operating Profit
158.54 53.01 151.56 -29.56 -172.52
Other Income
11.32 43.18 14.58 4.99 1.74
Depreciation
56.97 59.12 60.72 62.39 48.1
Interest
78.81 79.49 87.14 74.58 53.49
Profit before tax and exceptio..
34.08 -42.42 18.27 -161.53 -272.37
Exceptional Items
0 0 0 0 0
PBT
34.08 -42.42 18.27 -161.53 -272.37
Provision for Taxation
9.03 -18.24 13.27 -47.85 -86.57
Net Profit
25.05 -24.18 5 -113.68 -361.49
NET Profit after MI
25.05 -24.18 5 -113.68 -361.49
EPS
1.12 -1.08 0.22 -5.07 -16.11
Operating Profit Margin (%)
9.5 3.48 9 -1.77 -14.73
Net Profit Margin (%)
1.5 -1.59 0.3 -6.81 -30.86

Nectar Lifesciences Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: